跳至主要内容
临床试验/NCT07283536
NCT07283536撤回不适用

Two-site Blind Epidural Patch Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension: A Prospective, Assessor Blind, Randomized, Controlled, Noninferiority Trial

Beijing Tiantan Hospital0 个研究点目标入组 58 人开始时间: 2025年12月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
58
主要终点
Pain NRS of orthostatic headache

研究概览

简要总结

Spontaneous intracranial hypotension (SIH) is a condition characterized by refractory orthostatic headache, mostly due to loss of cerebrospinal fluid (CSF). Epidural patch with autologous platelet-rich plasma (PRP), which contains numerous growth factors and cytokines, has been reported as a successful alternative for whole blood in dura repair. However, there is no report regarding the best approach to use: targeted epidural PRP patch (TEPP) versus blind epidural PRP patch (BEPP). Preliminary work has suggested that both targeted and blind approaches are effective when using whole blood for epidural patch. Furthermore, two-site blind approach could be considered as a viable initial treatment regardless of the identification of the leak for conventional targeted approach. In this study, the investigators aimed to investigate the non-inferiority of two-site BEPP compared with TEPP for the treatment of refractory SIH cases failing in conservative therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent to participate the research obtained from the patient.
  • Age 18-65 years.
  • Satisfies the criteria for SIH according to the International Classification of Headache Disorders criteria for headaches attributed to spontaneous (or idiopathic) low CSF pressure.
  • Failed conservative management (bed rest oral or intravenous hydration, and analgesics) lasting at least 2 weeks.

排除标准

  • There was concern for other causes of intracranial hypotension, such as postdural puncture, postsurgical and post-traumatic CSF leaks.
  • Prior treatment with EBP at any time previously.
  • Any contraindication to epidural puncture, such as space-occupying intracranial or intraspinal lesions, spinal defect, suspected infection over the puncture site, bleeding disorder and current anticoagulation therapy.
  • History of drug and alcohol abuse, cognitive dysfunction, or mental illness.
  • Unable to comprehend the pain NRS.
  • Unable to cooperate with postoperative treatment, rehabilitation, and follow-up visits.

研究组 & 干预措施

Blind epidural PRP patch (BEPP)

Experimental

Two-site blind epidural patch with PRP, which was prepared with the 2-stage centrifugation method, at levels C7-T1 and L4-5.

干预措施: Blind epidural PRP patch (Procedure)

Targeted epidural PRP patch (TEPP)

Active Comparator

Targeted epidural patch with autologous platelet-rich plasma, which was prepared with the 2-stage centrifugation method.

干预措施: Targeted epidural PRP patch (Procedure)

结局指标

主要结局

Pain NRS of orthostatic headache

时间窗: 48 hours following epidural patch with PRP

Pain intensity was evaluated by pain numeric rating scale (NRS; 0 = no pain, 10 = unbearable pain) for headache.

次要结局

  • The good response rate of epidural patch with PRP(48 hours, 1, 3 and 6 months post-procedurally)
  • Pain NRS of orthostatic headache(1, 3 and 6 months following epidural patch with PRP)
  • The complete relief rate of epidural patch with PRP(48 hours, 1, 3 and 6 months after the initial targeted or blind patch)
  • The recurrence rate in each group.(During the 6-month follow up)
  • The failure rate of epidural patch with PRP(48 hours following the initial epidural patch with PRP)
  • The occurrence of complications(During and after the epidural patch with PRP until the end of 6-month follow up)
  • The percent of patients requiring repeat epidural PRP patch(During the 6- month follow up)
  • Patients' overall satisfaction(6 months following the first epidural patch with PRP)

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fang Luo

Professor

Beijing Tiantan Hospital

相似试验